<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00741182</url>
  </required_header>
  <id_info>
    <org_study_id>FAO_06_011</org_study_id>
    <secondary_id>EudraCT 2008-000094-37</secondary_id>
    <nct_id>NCT00741182</nct_id>
  </id_info>
  <brief_title>Effect of PTH(1-34) Treatment on Fracture Healing in Vivo</brief_title>
  <official_title>Effect of PTH(1-34) Treatment on Fracture Healing in Vivo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Danish Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture
      healing in postmenopausal women with fractures of the hip or shoulder.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">September 2010</completion_date>
  <primary_completion_date type="Anticipated">September 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiological evaluation of healing</measure>
    <time_frame>0, 4, 8, 12, (16) weeks after fracture</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical bone markers</measure>
    <time_frame>0, 1, 2, 3, 4, 8, 12, (16) weeks after fracture</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>0, 4, 8, 12, (16) weeks after fracture</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Shoulder Fractures</condition>
  <condition>Trochanteric Fractures</condition>
  <arm_group>
    <arm_group_label>Femur PTH(1-34)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 participants with trochanteric fractures will be assigned to Forsteo (PTH(1-34)) treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femur Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>24 participants with trochanteric fractures will be assigned to &quot;no treatment&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Humerus PTH(1-34)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 participants with collum chirurgicum fracture will be assigned to Forsteo (PTH(1-34)) treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Humerus Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>24 participants with collum chirurgicum fracture will be assigned to &quot;no treatment&quot;.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rhPTH(1-34)</intervention_name>
    <description>Injection of 20 micrograms per day in eight weeks</description>
    <arm_group_label>Femur PTH(1-34)</arm_group_label>
    <arm_group_label>Humerus PTH(1-34)</arm_group_label>
    <other_name>Forsteo</other_name>
    <other_name>Forteo</other_name>
    <other_name>Teriparatide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute new osteoporotic trochanteric or collum chirurgicum fracture

          -  Postmenopause

        Exclusion Criteria:

          -  Calcium metabolic disease other than osteoporosis

          -  Diseases known to affect calcium homeostasis

          -  Dementia

          -  Hypersensitivity to drug or other components of medication

          -  pre-existing hypercalcemia

          -  Decreased kidney function

          -  Increased alkaline phosphatase

          -  Prior external radiation therapy or brachytherapy of the skeleton

          -  Skeletal malignancies or bone metastases

          -  Alcohol and/or drug abuse

          -  Systemic treatment with corticosteroids within the last four weeks

          -  Non-cooperating patients

          -  Patients who do not speak and understand the danish language
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Schwarz, MD, DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Center for Ageing and Osteoporosis, Glostrup University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2008</study_first_submitted>
  <study_first_submitted_qc>August 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2008</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2015</last_update_posted>
  <responsible_party>
    <name_title>Peter Schwarz, Professor, MD, DMSci</name_title>
    <organization>Glostrup University Hospital</organization>
  </responsible_party>
  <keyword>Fracture</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>Forsteo</keyword>
  <keyword>Teriparatide</keyword>
  <keyword>Fracture healing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Teriparatide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

